Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis

Veterinary Immunology and Immunopathology

Volumn 102, Issue 1-2, 2004, Pages 19-31

  Shida, Masayuki ^a   Kadoya, Michiyo ^a   Park, Seong Jun ^a   Nishifuji, Koji ^a   Momoi, Yasuyuki ^a   Iwasaki, Toshiroh ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Allergen specific immunotherapy; Atopic dermatitis; Dog; IFN ; IL 4

Indexed keywords

GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BLOOD SAMPLING; CELL POLARITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; DRUG EFFECT; FEMALE; IMMUNOTHERAPY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DOG DISEASES; DOGS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERFERON TYPE II; INTERLEUKIN-4; MALE; PYROGLYPHIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TH1 CELLS; TH2 CELLS;

ACARI; ASTIGMATA; CANIS FAMILIARIS; PYROGLYPHIDAE;

EID: 4644289535     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.06.003     Document Type: Article

References (40)

1. Baker E. Management of allergic disease by hyposensitization. J. Am. Vet. Med. Assoc. 154:1967;491-494
2. Benjaponpitak S., Oro A., Maguire P., Marinkovich V., DeKruyff R.H., Umetsu D.T. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J. Allergy Clin. Immunol. 103:1999;468-475
3. Bonifazi F., Antonicelli L., Bilo M.B., Pucci S., Taylor I.H., Wheeler A.W., Youlten L.J. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria). J. Invest. Allergol. Clin. Immunol. 1:1991;37-44
4. Byron K.A., O'Brien M.R., Varigos G.A., Wootton A.M. Dermatophagoides pteronyssinus II-induced interleukin-4 and interferon-γ expression by freshly isolated lymphocytes of atopic individuals. Clin. Exp. Allergy. 24:1994;878-883
5. Calbi M., Scarpellino B., Giacchetti L. Usefulness of neonatal eosinophil counts as a marker of atopy? Pediatr. Allergy Immunol. 4:1993;86-88
6. Ebner C., Siemann U., Bohle B., Willheim M., Wiedermann U., Schenk S., Klotz F., Ebner H., Kraft D., Scheiner O. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin. Exp. Allergy. 27:1997;1007-1015
7. Esnault S., Benbernou N., Lavaud F., Shin H.C., Potron G., Guenounou M. Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-γ) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin. Exp. Immunol. 103:1996;111-118
8. Essayan D.M., Han W., Li X., Xiao H., Kliene-Tebbe J., Huang S. Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes. J. Allergy Clin. Immunol. 98:1996;1035-1044
9. Gabrielsson S., Paulie S., Rak S., Lagging E., Van Hage-Hamsten M., Harfast B., Troye-Blomberg M. Specific induction of interleukin-4-producing cells in response to in vitro allergen stimulation in atopic individuals. Clin. Exp. Allergy. 27.:1997;808-815
10. Halliwell, R.E.W., 1977. Hyposensitization in the treatment of atopic disease. In: Kirk, R.W. (Ed.), Current Veterinary Therapy, vol. IV. Saunders, Philadelphia, PA, pp. 537-541.
11. Hayashiya S., Tani K., Morimoto M., Hayashi T., Hayasaki M., Nomura T., Une S., Nakaichi M., Taura Y. Expression of T helper 1 and T helper 2 cytokine mRNAs in freshly isolated peripheral blood mononuclear cells from dogs with atopic dermatitis. J. Vet. Med. A. Physiol. Pathol. Clin. Med. 49:2002;27-31
12. Hites M.J., Kleinbeck M.L., Loker J.L., Lee K.W. Effect of immunotherapy on the serum concentrations of allergen-specific IgG antibodies in dog sera. Vet. Immunol. Immunopathol. 22:1989;39-51
13. Jutel M., Pichler W.J., Skrbic D., Urwyler A., Dahinden C., Müller U.R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154:1995;4187-4194
14. Kiehl P., Falkenberg K., Vogelbruch M., Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br. J. Dermatol. 145:2001;720-729
15. Kikkawa Y., Motoki Y., Maruyama K., Kojima Y., Iwatsuki K., Kaneko F. Interleukin (IL)-6 production by peripheral blood mononuclear cells stimulated with house dust mite antigen and serum IL-6 in patients with adult type atopic dermatitis. Jpn. J. Dermatol. 104:1994;1339-1345. (in Japanese)
16. Kimura M., Tsuruta S., Yoshida T. Unique profile of IL-4 and IFN-γ production by peripheral blood mononuclear cells in infants with atopic dermatitis. J. Allergy Clin. Immunol. 102:1998;238-244
17. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:1988;219-224
18. Lu F.M., Chou C.C., Chiang B.L., Hsieh K.H. Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. Ann. Allergy Asthma Immunol. 80:1998;419-423
19. Moverare R., Elfman L., Bjornsson E., Stalenheim G. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy. Immunol. Lett. 73:2000;51-56
20. Norman P.S. Immunotherapy: past and present. J. Allergy Clin. Immunol. 101:1998;403-404
21. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., Hill P.B. T-helper 1, T-helper 2 and immunosuppressive cytokine in canine atopic dermatitis. Vet. Immunol. Immunopathol. 87:2002;379-384
22. O'Brien R.M., Byron K.A., Varigos G.A., Thomas W.R. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-γ and IL-4 expression by circulating T lymphocytes. Clin. Exp. Allergy. 27:1997;46-51
23. Olivry T., Dean G.A., Tompkins M.B., Dow J.L., Moore P.F. Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp. Dermatol. 8:1999;204-211
24. Olivry T., Moore P.F., Affolter V.K., Naydan D.K. Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis. Arch. Dermatol. Res. 288:1996;579-585
25. Pumhirun P., Tuchinda S., Nondavanich A., Jarujinda S., Poommark C. Immunological and clinical evaluation during a 12-month period of immunotherapy. Asian Pac. J. Allergy Immunol. 12:1994;111-115
26. Reedy, L.M., Miller Jr., W.H., Willemse, T., 1997. Medical management of allergic disease. In: Allergic Skin Disease of Dog and Cat, second ed. Saunders, Philadelphia, PA, pp. 150-172.
27. Rhodes K.H., Kerdel F., Soter N.A. Comparative aspects of canine and human atopic dermatitis. Semin. Vet. Med. Surg. (Small Anim.). 2:1987a;166-172
28. Rhodes K.H., Kerdel F., Soter N.A. Investigation into the immunopathogenesis of canine atopy. Semin. Vet. Med. Surg. (Small Anim.). 2:1987b;199-201
29. Rothe M.J., Grant-Kels J.M. Atopic dermatitis: an update. J. Am. Acad. Dermatol. 35:1996;1-13
30. Schwartz R.H. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1996;1-8
31. Scott D.W. Observation in canine atopy. J. Anim. Hosp. Assoc. 17:1981;91-95
32. Scott, D.W., Miller Jr., W.H., Griffin, C.E., 2001. Skin immune system and allergic skin disease. In: Muller and Kirk's Small Animal Dermatology, sixth ed. Saunders, Philadelphia, PA, pp. 543-666.
33. Secrist H., DeKruyff R.H., Umetsu D.T. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1995;1081-1089
34. Strasser A., Kalmar E., Niedermüller H. A simple method for the simultaneous separation of peripheral blood mononuclear and polymorphonuclear cells in the dog. Vet. Immunol. Immunopathol. 62:1998;29-35
35. Theodoropoulos D.S., Lockey R.F. Allergen immunotherapy: guidelines, update and recommendations of the World Health Organization. Allergy Asthma Proc. 21:2000;159-166
36. Varney V.A., Hamid Q.A., Gaga M., Ying S., Jacobson M., Frew A.J., Kay A.B., Durham S.R. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92:1993;644-651
37. Willemse T. Atopic skin disease: a review and re-consideration of diagnostic criteria. J. Small Anim. Pract. 27:1986;771-778
38. Willemse A., Van den Brom W.E., Rijnberk A. Effect of hyposensitization on atopic dermatitis in dogs. J. Am. Vet. Med. Assoc. 184:1984;1277-1280
39. Wunderli P.S., Felsburg P.J. An improved method for the isolation of enriched canine peripheral blood mononuclear cell and peripheral blood lymphocyte preparations. Vet. Immunol. Immunopathol. 20:1989;334-335
40. Zunic M. Comparison between IMMUNODOT tests and the intradermal skin test in atopic dogs. Vet. Dermatol. 9:1998;201-205